VSee Health, Inc. Common Stock, Par or Stated Value Per Share
VSee Health, Inc. (VSEE) had Common Stock, Par or Stated Value Per Share of $0.00 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockParOrStatedValuePerShare · last filed 2026-08-14
- 2026-06-30: Common Stock, Par or Stated Value Per Share $0.00.
- 2026-03-31: Common Stock, Par or Stated Value Per Share $0.00.
- 2026-01-16: Common Stock, Par or Stated Value Per Share $2000000.00.
- 2025-12-31: Common Stock, Par or Stated Value Per Share $0.00.
| Period end | Common Stock, Par or Stated Value Per Share |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 |
| 2026-01-16 | $2000000.00 10-Q · filed 2026-08-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $0.00 10-Q/A · filed 2025-11-20 |
| 2025-03-31 | $0.00 10-Q · filed 2025-10-15 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-09-23 |
| 2024-06-24 | $0.00 10-K · filed 2026-03-31 |
| 2023-12-31 | $0.00 10-K/A · filed 2025-08-29 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-K · filed 2023-04-12 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |